These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 14664827

  • 1. Distinct elements of the peripheral myelin protein 22 (PMP22) promoter regulate expression in Schwann cells and sensory neurons.
    Maier M, Castagner F, Berger P, Suter U.
    Mol Cell Neurosci; 2003 Nov; 24(3):803-17. PubMed ID: 14664827
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Hypermyelination and demyelinating peripheral neuropathy in Pmp22-deficient mice.
    Adlkofer K, Martini R, Aguzzi A, Zielasek J, Toyka KV, Suter U.
    Nat Genet; 1995 Nov; 11(3):274-80. PubMed ID: 7581450
    [Abstract] [Full Text] [Related]

  • 4. Distinct disease mechanisms in peripheral neuropathies due to altered peripheral myelin protein 22 gene dosage or a Pmp22 point mutation.
    Giambonini-Brugnoli G, Buchstaller J, Sommer L, Suter U, Mantei N.
    Neurobiol Dis; 2005 Apr; 18(3):656-68. PubMed ID: 15755691
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Tead1 regulates the expression of Peripheral Myelin Protein 22 during Schwann cell development.
    Lopez-Anido C, Poitelon Y, Gopinath C, Moran JJ, Ma KH, Law WD, Antonellis A, Feltri ML, Svaren J.
    Hum Mol Genet; 2016 Jul 15; 25(14):3055-3069. PubMed ID: 27288457
    [Abstract] [Full Text] [Related]

  • 7. Identification of a positive regulatory element in the myelin-specific promoter of the PMP22 gene.
    Hai M, Bidichandani SI, Patel PI.
    J Neurosci Res; 2001 Sep 15; 65(6):508-19. PubMed ID: 11550219
    [Abstract] [Full Text] [Related]

  • 8. Tetraspan myelin protein PMP22 and demyelinating peripheral neuropathies: new facts and hypotheses.
    Müller HW.
    Glia; 2000 Jan 15; 29(2):182-5. PubMed ID: 10625337
    [Abstract] [Full Text] [Related]

  • 9. Distal axonopathy in peripheral nerves of PMP22-mutant mice.
    Sancho S, Magyar JP, Aguzzi A, Suter1 U.
    Brain; 1999 Aug 15; 122 ( Pt 8)():1563-77. PubMed ID: 10430839
    [Abstract] [Full Text] [Related]

  • 10. Induced myelination and demyelination in a conditional mouse model of Charcot-Marie-Tooth disease type 1A.
    Perea J, Robertson A, Tolmachova T, Muddle J, King RH, Ponsford S, Thomas PK, Huxley C.
    Hum Mol Genet; 2001 May 01; 10(10):1007-18. PubMed ID: 11331611
    [Abstract] [Full Text] [Related]

  • 11. Many facets of the peripheral myelin protein PMP22 in myelination and disease.
    Naef R, Suter U.
    Microsc Res Tech; 1998 Jun 01; 41(5):359-71. PubMed ID: 9672419
    [Abstract] [Full Text] [Related]

  • 12. Charcot-Marie-Tooth disease and related inherited neuropathies.
    Murakami T, Garcia CA, Reiter LT, Lupski JR.
    Medicine (Baltimore); 1996 Sep 01; 75(5):233-50. PubMed ID: 8862346
    [Abstract] [Full Text] [Related]

  • 13. Stoichiometric alteration of PMP22 protein determines the phenotype of hereditary neuropathy with liability to pressure palsies.
    Li J, Ghandour K, Radovanovic D, Shy RR, Krajewski KM, Shy ME, Nicholson GA.
    Arch Neurol; 2007 Jul 01; 64(7):974-8. PubMed ID: 17620487
    [Abstract] [Full Text] [Related]

  • 14. Impairment of PMP22 transgenic Schwann cells differentiation in culture: implications for Charcot-Marie-Tooth type 1A disease.
    Nobbio L, Vigo T, Abbruzzese M, Levi G, Brancolini C, Mantero S, Grandis M, Benedetti L, Mancardi G, Schenone A.
    Neurobiol Dis; 2004 Jun 01; 16(1):263-73. PubMed ID: 15207283
    [Abstract] [Full Text] [Related]

  • 15. Molecular alterations resulting from frameshift mutations in peripheral myelin protein 22: implications for neuropathy severity.
    Johnson JS, Roux KJ, Fletcher BS, Fortun J, Notterpek L.
    J Neurosci Res; 2005 Dec 15; 82(6):743-52. PubMed ID: 16273544
    [Abstract] [Full Text] [Related]

  • 16. Alterations in degradative pathways and protein aggregation in a neuropathy model based on PMP22 overexpression.
    Fortun J, Go JC, Li J, Amici SA, Dunn WA, Notterpek L.
    Neurobiol Dis; 2006 Apr 15; 22(1):153-64. PubMed ID: 16326107
    [Abstract] [Full Text] [Related]

  • 17. Phenotypic differences between peripheral myelin protein-22 (PMP22) and myelin protein zero (P0) mutations associated with Charcot-Marie-Tooth-related diseases.
    Shames I, Fraser A, Colby J, Orfali W, Snipes GJ.
    J Neuropathol Exp Neurol; 2003 Jul 15; 62(7):751-64. PubMed ID: 12901701
    [Abstract] [Full Text] [Related]

  • 18. Studies on the effects of altered PMP22 expression during myelination in vitro.
    D'Urso D, Schmalenbach C, Zoidl G, Prior R, Müller HW.
    J Neurosci Res; 1997 Apr 01; 48(1):31-42. PubMed ID: 9086179
    [Abstract] [Full Text] [Related]

  • 19. Neuregulin 1-erbB signaling is necessary for normal myelination and sensory function.
    Chen S, Velardez MO, Warot X, Yu ZX, Miller SJ, Cros D, Corfas G.
    J Neurosci; 2006 Mar 22; 26(12):3079-86. PubMed ID: 16554459
    [Abstract] [Full Text] [Related]

  • 20. PMP22 overexpression causes dysmyelination in mice.
    Robaglia-Schlupp A, Pizant J, Norreel JC, Passage E, Sabéran-Djoneidi D, Ansaldi JL, Vinay L, Figarella-Branger D, Lévy N, Clarac F, Cau P, Pellissier JF, Fontés M.
    Brain; 2002 Oct 22; 125(Pt 10):2213-21. PubMed ID: 12244079
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.